Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.

As Ozempic and other GLP-1 drugs explode in popularity ... the allure of a "miracle" weight loss solution – an average 15% weight reduction, according to clinical research – that reduces ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation ... significant long-term CV benefits. Reduction in weight, blood pressure ...

while navigating the surge in evidence for GLP-1 applications beyond diabetes and obesity, allowing you to chart your course for success in GLP-1 development, placing you at the front this ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

RAWA officials say they believe if people do their part, the authority won't have to increase to a 20% water reduction. "With the amount of water we can get from Western Berks, and the amount of ...

Diabetes may play a role in your weight, including weight loss, when you have type 1 or type 2 diabetes. This can be a symptom of unmanaged or undiagnosed diabetes, but it can also be due to other ...